Based on analysis of the interaction of the designed hybrid Antp-TPR peptide with human Hsp90 protein, we then examined cancer-cell viability to assess the selectivity of this peptide in discriminating between normal and cancer cells. The gene discussed is HSP90AA1; the disease is cancer.